Oritavancin as sequential therapy for Gram-positive bloodstream infections

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Oritavancin as sequential therapy for Gram-positive bloodstream infections ; volume:24 ; number:1 ; day:24 ; month:1 ; year:2024 ; pages:1-6 ; date:12.2024
BMC infectious diseases ; 24, Heft 1 (24.1.2024), 1-6, 12.2024

Creator: Texidor, Williams Monier
Miller, Matthew A.
Molina, Kyle C.
Krsak, Martin
Calvert, Barbara
Hart, Caitlin
Storer, Marie
Fish, Douglas N.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12879-023-08725-8

URN: urn:nbn:de:101:1-2024040509410036296223

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:53 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Texidor, Williams Monier
Miller, Matthew A.
Molina, Kyle C.
Krsak, Martin
Calvert, Barbara
Hart, Caitlin
Storer, Marie
Fish, Douglas N.
SpringerLink (Online service)

Other Objects (12)

Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study

Routine laboratory biomarkers used to predict Gram-positive or Gram-negative bacteria involved in bloodstream infections

CSF inflammatory markers differ in gram-positive versus gram-negative shunt infections

Evaluation of a new Rapid Antimicrobial Susceptibility system for Gram-negative and Gram-positive bloodstream infections: speed and accuracy of Alfred 60AST

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

Epidemiology and microbiology of Gram-positive bloodstream infections in a tertiary-care hospital in Beijing, China: a 6-year retrospective study

Prior statin use and 90-day mortality in Gram-negative and Gram-positive bloodstream infection: a prospective observational study

Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections

Daptomycin for the treatment of major gram-positive infections after cardiac surgery

Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study

Routine laboratory biomarkers used to predict Gram-positive or Gram-negative bacteria involved in bloodstream infections

CSF inflammatory markers differ in gram-positive versus gram-negative shunt infections

Evaluation of a new Rapid Antimicrobial Susceptibility system for Gram-negative and Gram-positive bloodstream infections: speed and accuracy of Alfred 60AST

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

Epidemiology and microbiology of Gram-positive bloodstream infections in a tertiary-care hospital in Beijing, China: a 6-year retrospective study

Prior statin use and 90-day mortality in Gram-negative and Gram-positive bloodstream infection: a prospective observational study

Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections

Daptomycin for the treatment of major gram-positive infections after cardiac surgery

Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study

Routine laboratory biomarkers used to predict Gram-positive or Gram-negative bacteria involved in bloodstream infections

CSF inflammatory markers differ in gram-positive versus gram-negative shunt infections

Evaluation of a new Rapid Antimicrobial Susceptibility system for Gram-negative and Gram-positive bloodstream infections: speed and accuracy of Alfred 60AST

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

Epidemiology and microbiology of Gram-positive bloodstream infections in a tertiary-care hospital in Beijing, China: a 6-year retrospective study

Prior statin use and 90-day mortality in Gram-negative and Gram-positive bloodstream infection: a prospective observational study

Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections

Daptomycin for the treatment of major gram-positive infections after cardiac surgery

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Oritavancin as sequential therapy for Gram-positive bloodstream infections

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study

Routine laboratory biomarkers used to predict Gram-positive or Gram-negative bacteria involved in bloodstream infections

CSF inflammatory markers differ in gram-positive versus gram-negative shunt infections

Evaluation of a new Rapid Antimicrobial Susceptibility system for Gram-negative and Gram-positive bloodstream infections: speed and accuracy of Alfred 60AST

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

Epidemiology and microbiology of Gram-positive bloodstream infections in a tertiary-care hospital in Beijing, China: a 6-year retrospective study

Prior statin use and 90-day mortality in Gram-negative and Gram-positive bloodstream infection: a prospective observational study

Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections

Daptomycin for the treatment of major gram-positive infections after cardiac surgery

Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study

Routine laboratory biomarkers used to predict Gram-positive or Gram-negative bacteria involved in bloodstream infections

CSF inflammatory markers differ in gram-positive versus gram-negative shunt infections

Evaluation of a new Rapid Antimicrobial Susceptibility system for Gram-negative and Gram-positive bloodstream infections: speed and accuracy of Alfred 60AST

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

Epidemiology and microbiology of Gram-positive bloodstream infections in a tertiary-care hospital in Beijing, China: a 6-year retrospective study

Prior statin use and 90-day mortality in Gram-negative and Gram-positive bloodstream infection: a prospective observational study

Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections

Daptomycin for the treatment of major gram-positive infections after cardiac surgery

Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study

Routine laboratory biomarkers used to predict Gram-positive or Gram-negative bacteria involved in bloodstream infections

CSF inflammatory markers differ in gram-positive versus gram-negative shunt infections

Evaluation of a new Rapid Antimicrobial Susceptibility system for Gram-negative and Gram-positive bloodstream infections: speed and accuracy of Alfred 60AST

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

Epidemiology and microbiology of Gram-positive bloodstream infections in a tertiary-care hospital in Beijing, China: a 6-year retrospective study

Prior statin use and 90-day mortality in Gram-negative and Gram-positive bloodstream infection: a prospective observational study

Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections

Daptomycin for the treatment of major gram-positive infections after cardiac surgery

Related objects

Reset password